Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer

Gynecologic Oncology ◽

10.1006/gyno.2000.6015 ◽

2001 ◽

Vol 80 (1) ◽

pp. 48-55 ◽

Author(s):

Coşkun Tecimer ◽

David L. Doering ◽

L.Jane Goldsmith ◽

John S. Meyer ◽

Gazi Abdulhay ◽

...

Keyword(s):

Endometrial Cancer ◽

Plasminogen Activator ◽

Clinical Relevance ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Download Full-text

Clinical relevance of urokinase-type plasminogen activator and its inhibitor type 1 (PAI-1) in squamous cell carcinoma of the uterine cervix

Australian and New Zealand Journal of Obstetrics and Gynaecology ◽

10.1111/j.0004-8666.2002.00385.x ◽

2002 ◽

Vol 42 (4) ◽

pp. 385-388 ◽

Author(s):

LC Horn ◽

S Pippig ◽

G Raptis ◽

U Fischer ◽

U Kohler ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Plasminogen Activator ◽

Uterine Cervix ◽

Clinical Relevance ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Download Full-text

Clinical Relevance of Invasion Factors Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 for Individualized Therapy Decisions in Primary Breast Cancer Is Greatest When Used in Combination

Journal of Clinical Oncology ◽

10.1200/jco.20.4.1000 ◽

2002 ◽

Vol 20 (4) ◽

pp. 1000-1007 ◽

Author(s):

N. Harbeck

Keyword(s):

Breast Cancer ◽

Plasminogen Activator ◽

Clinical Relevance ◽

Plasminogen Activator Inhibitor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer

International Journal of Gynecological Cancer ◽

10.1046/j.1525-1438.2000.010005372.x ◽

2000 ◽

Vol 10 (5) ◽

pp. 372-381 ◽

Author(s):

C. Tecimer ◽

D. L. Doering ◽

L. J. Goldsmith ◽

J. S. Meyer ◽

G. Abdulhay ◽

...

Keyword(s):

Ovarian Cancer ◽

Plasminogen Activator ◽

Clinical Relevance ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Download Full-text

Urokinase type plasminogen activator and inhibitor type-1 plasma levels in colorectal cancer

Gastroenterology ◽

10.1016/s0016-5085(01)82981-4 ◽

2001 ◽

Vol 120 (5) ◽

pp. A599-A600 ◽

Author(s):

L HERSZENYI ◽

F FARINATI ◽

G ISTVAN ◽

M PAOLI ◽

G ROVERONI ◽

...

Keyword(s):

Colorectal Cancer ◽

Plasminogen Activator ◽

Plasma Levels ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Download Full-text

Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2004.n.040 ◽

2004 ◽

Vol 5 (5) ◽

pp. 348-352 ◽

Author(s):

Nadia Harbeck ◽

Ronald E. Kates ◽

Manfred Schmitt ◽

Katja Gauger ◽

Marion Kiechle ◽

...

Keyword(s):

Breast Cancer ◽

Plasminogen Activator ◽

Primary Breast Cancer ◽

Therapy Response ◽

Disease Outcome ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Download Full-text

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors

Fibrinolysis and Proteolysis ◽

10.1016/0268-9499(94)90453-7 ◽

1994 ◽

Vol 8 ◽

pp. 61 ◽

Author(s):

B. Landau ◽

S. Brern ◽

E. Verrusio ◽

H. Kwaan

Keyword(s):

Brain Tumors ◽

Human Brain ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

92 Single chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1

Fibrinolysis and Proteolysis ◽

10.1016/s0268-9499(96)80179-2 ◽

1996 ◽

Vol 10 ◽

pp. 30

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Single Chain ◽

Plasminogen Activator Inhibitor Type ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Type-1 mRNA Assessment in Breast Cancer by Means of NASBA

American Journal of Clinical Pathology ◽

10.1309/k4jaf2nmd5eju67y ◽

2007 ◽

Vol 128 (3) ◽

pp. 404-413 ◽

Author(s):

Pierre-Jean Lamy ◽

Thibault Verjat ◽

Anne-Claire Servanton ◽

Malik Paye ◽

Philippe Leissner ◽

...

Keyword(s):

Breast Cancer ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Correlation between protein and RNA tissue concentration of invasion factors urokinase-type plasminogen activator (uPA) and its inhibitor, plasminongen activator inhibitor type 1 (PAI-1)

Zentralblatt für Gynäkologie ◽

10.1055/s-2005-921021 ◽

2005 ◽

Vol 127 (04) ◽

Author(s):

M Bader ◽

C Thomssen ◽

E Laczynska ◽

M Gehrmann ◽

M Munnes ◽

...

Keyword(s):

Plasminogen Activator ◽

Tissue Concentration ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor ◽

Download Full-text

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer

10.1186/1471-2407-8-194 ◽

2008 ◽

Vol 8 (1) ◽

Author(s):

László Herszényi ◽

Fabio Farinati ◽

Romilda Cardin ◽

Gábor István ◽

László D Molnár ◽

...

Keyword(s):

Plasminogen Activator ◽

Cathepsin B ◽

Cathepsin L ◽

Plasminogen Activator Inhibitor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text